CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2014; 05(01): 018-021
DOI: 10.4103/0976-5042.141928
Original Article
Society of Gastrointestinal Endoscopy of India

An audit of lidocaine spray and its use in endoscopy with particular attention to its ethanol content

Affifa Farrukh
Department of Digestive Diseases, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
,
James Stewart
Department of Digestive Diseases, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
26 September 2019 (online)

Abstract

Objective: The aim was to investigate the attitude of patients about to undergo upper gastrointestinal endoscopy toward the use of an oral lidocaine spray which contained alcohol.

Materials and Method: It is customary to offer patients about to undergo a gastroscopy intravenous sedation, an oral local anesthetic spray or a combination of both. However, the presence of alcohol within the oral spray is seldom discussed with patients. There are some religious groups, such as fundamentalist Christians and Muslims, who will only consider the use of alcohol in exceptional circumstances. There are also others who are reluctant to use it for a range of reasons. One hundred patients undergoing a diagnostic gastroscopy because of dyspeptic symptoms at the University Hospitals of Leicester were provided with an information sheet about sedation. Of the 100 patients asked to take part in the audit 25 were South Asian. Eleven of these patients were Muslim and 11 Hindu. Results: Fifteen patients declined to use the spray (13 Europeans and 2 South Asians). The reasons varied with only two doing so for religious reasons. One of the patients was a Muslim and the other a Christian. However, almost 90% of people believed all patients should be told of the alcohol content of the oral spray so as to allow them to make an informed choice. Conclusion: All patients who are to undergo an endoscopy should be told of the alcohol content of any oral anesthetic spray, so that they can make an informed choice as to whether they wish to receive it.

 
  • References

  • 1 Jenkins ED, Yip M, Melman L, Frisella MM, Matthews BD. Informed consent: Cultural and religious issues associated with the use of allogeneic and xenogeneic mesh products. J Am Coll Surg 2010;210:402-10.
  • 2 Sattar SP, Shakeel Ahmed M, Majeed F, Petty F. Inert medication ingredients causing nonadherence due to religious beliefs. Ann Pharmacother 2004;38:621-4.
  • 3 Curlin FA, Roach CJ, Gorawara-Bhat R, Lantos JD, Chin MH. When patients choose faith over medicine: Physician perspectives on religiously related conflict in the medical encounter. Arch Intern Med 2005;165:88-91.
  • 4 Gatrad AR, Mynors G, Hunt P, Sheikh A. Patient choice in medicine taking: Religious sensitivities must be respected. Arch Dis Child 2005;90:983-4.
  • 5 Shokar NK, Carlson CA, Weller SC. Informed decision making changes test preferences for colorectal cancer screening in a diverse population. Ann Fam Med 2010;8:141-50.
  • 6 Ubel PA. Is information always a good thing? Helping patients make “good” decisions. Med Care 2002;40:V39-44.
  • 7 Lidocaine 10% W/W Local Anaesthetic SPRAY PL 20165/0009 UKPAR. Available from: http://www.mhra.gov.uk/home/groups/l-unit1/documents/websiteresources/con2033475.pdf . [Last accessed on 2013 Aug 18].
  • 8 Smith JL, Opekun A, Graham DY. Controlled comparison of topical anesthetic agents in flexible upper gastrointestinal endoscopy. Gastrointest Endosc 1985;31:255-8.
  • 9 Froehlich F, Schwizer W, Thorens J, Köhler M, Gonvers JJ, Fried M Conscious sedation for gastroscopy: Patient tolerance and cardiorespiratory parameters. Gastroenterology 1995;108:697-704.
  • 10 Leitch DG, Wicks J, el Beshir OA, Ali SA, Chaudhury BK. Topical anesthesia with 50 mg of lidocaine spray facilitates upper gastrointestinal endoscopy. Gastrointest Endosc 1993;39:384-7.
  • 11 Wong KF, Leung SK, Lau KW. A randomised controlled trial to compare the efficacy of xylocaine spray and amethocaine lozenge in preparing patients for oesophago-gastro-duodenoscopy (OGD). Ann Coll Surg Hong Kong 2004;8:A8.
  • 12 Muller G Rph, Case T Dds, Deen GL Dds. Tetracaine lollipops for the suppression of extreme gag reflex in dental patients. Int J Pharm Compd 2010;14:395-99.
  • 13 Asante MA, Northfield TC. Variation in taste of topical lignocaine anaesthesia for gastroscopy. Aliment Pharmacol Ther 1998;12:685-6.
  • 14 Chan CK, Fok KL, Poon CM. Flavored anesthetic lozenge versus xylocaine spray used as topical pharyngeal anesthesia for unsedated esophagogastroduodenoscopy: A randomized placebo-controlled trial. Surg Endosc 2010;24:897-901.
  • 15 Pereira S, Hussaini SH, Hanson PJ, Wilkinson ML, Sladen GE. Informed consent for upper gastrointestinal endoscopy. J R Coll Physicians (Lond) 1994;28:411-4.
  • 16 Probert CS, Jayanthi V, Quinn J, Mayberry JF. Information requirements and sedation preferences of patients undergoing endoscopy of the upper gastrointestinal tract. Endoscopy 1991;23:218-9.